Autopsy report · NCT04222985

Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2

“business reasons-Phase 2/Part B not conducted. Study terminated after last patient enrolled in Phase 1/Part A”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 1 year 3 months before it stopped.
• 24 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Sanofi Pasteur, a Sanofi Company

Sponsor type

Industry

Conditions

Genital Herpes

Interventions

HSV 2 Formulation 1; HSV 2 Formulation 2; HSV 2 Formulation 3; HSV 2 Formulation 4; HSV 2 Formulation 5; HSV 2 Formulation 6

Participants

24

Sites

4

Countries

United States

Trials that died the same way

• A Study on the Safety and Efficacy of LAE001 in the Treatment of Metastatic Prostate Cancer
  “This is phase I/II study, phase I study completed, phase II study started and enrolled 1 patient. Company strategy consideration to terminated phase 2 study finally.” (81% match in meaning)
• Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome
  “This study was terminated early due to company decision. Part B was never conducted.” (74% match in meaning)
• Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients
  “Study was terminated early for strategic reasons. Only Part I of the study was completed.” (74% match in meaning)
• BI-1607 in Combination with Trastuzumab in Subjects with HER2-positive Advanced Solid Tumors
  “After the completion of phase IA, for business reasons it was decided to terminate the study.” (72% match in meaning)
• The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"
  “Study terminated due to lack of eligible patients” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.